BONUS CERTIFICATE - ROCHE GS Stock

Certificat

SAKJJB

CH1224529185

Market Closed - Swiss Exchange 11:20:00 2024-05-31 EDT
222.9 CHF +1.69% Intraday chart for BONUS CERTIFICATE - ROCHE GS
1 month+4.89%
3 months+2.25%
Date Price Change
24-05-31 222.9 +1.69%
24-05-30 219.2 -0.81%
24-05-28 221 -0.45%
24-05-27 222 -0.31%
24-05-24 222.7 -0.27%

Delayed Quote Swiss Exchange

Last update May 31, 2024 at 11:20 am

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Bank Julius Bär
SAKJJB
ISINCH1224529185
Date issued 2022-11-15
Strike 337.6 CHF
Maturity 2025-11-17 (534 Days)
Parity 1 : 1
Emission price 314.8 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 309.5 CHF
Lowest since issue 205.7 CHF
Spread 1.1 CHF
Spread %0.49%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
231 CHF
Average target price
277.5 CHF
Spread / Average Target
+20.14%
Consensus
  1. Stock Market
  2. Certificates
  3. SAKJJB Certificat